AUTH/3885/3/24 - Ever Pharma UK v Britannia Pharmaceuticals

Alleged off-licence promotion of APO-go

  • Case number
    AUTH/3885/3/24
  • Complaint received
    13 March 2024
  • Completed
    04 June 2025
  • Appeal hearing
    No appeal
  • Applicable Code year
    2021
  • No breach Clause(s)
  • Breach Clause(s)
  • Sanctions applied
    Undertaking received
  • Additional sanctions

Case Summary

This case was in relation to alleged off-licence promotion of Britannia Pharmaceuticals Ltd’s product APO-go (apomorphine hydrochloride) through its Nurse Service and at a sponsored meeting.

 The outcome under the 2021 Code was:

Breach of Clause 5.1(x2)

Failing to maintain high standards

Breach of Clause 11.2(x2)

Promoting a medicine for an unlicensed indication

 

No Breach of Clause 2

Requirement that activities or materials must not bring discredit upon, or reduce confidence in, the pharmaceutical industry

 This summary is not intended to be read in isolation.
For full details, please see the full case report below.